Glaxo Smith Kline reported standalone and consolidated earnings results for the quarter ended March 31, 2017. For the quarter, on standalone basis, the company reported net profit of EGP 16,709,229 compared to EGP 68,951,402 a year ago. For the quarter, on consolidated basis, the company reported net profit of EGP 18,216,449 compared to EGP 72,913,674 a year ago.